Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Submitted by
admin
on August 31, 2023 - 11:01am
Source:
Motley Fool
News Tags:
Medicare
JNJ
drug pricing
Headline:
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
snippet:
Three of Johnson & Johnson's blockbusters are on Medicare's price negotiation list.
Drugmakers have filed court cases fighting the government's plan to directly negotiate prices.
Do Not Allow Advertisers to Use My Personal information